a) Acute symptoms | ||||||||
---|---|---|---|---|---|---|---|---|
Region | EM | NA | ||||||
Country | Iran [106] | Iran [91] | Qatar [69] | Turkey [97] | Turkey [107] | Saudi Arabia [71] | Egypt [78]b | Morocco [104] |
Population type | GP | GP | GP | GP | GP | P | GP | GP |
Number of patients in study | 3 | 68 | 25 | 65 | 7 | 105 | 203 | 35 |
Date range, year | 2009–2011 | 1992–2002 | 1992–2008 | 2000–2005 | 1995–2003 | February–April 2000 | 1998–2004 | 2011–2013 |
Age range, year | Children (0.5–10) | Children (0–13) | Children, adults (0–68) | Children (0.5–10) | Children, adults (15–60) | Adults (18–80) | Children, adults (0–75) | Children (0–13) |
Symptoms | ||||||||
 Proportion of patients experiencing acute symptoms (%) | 0.0–100 | 8.8–64.7 | 4.0–80.0 | 7.7–95.4 | 71.4 | 28.6 | 16.0–79.0 | 5.7–65.7 |
 Stiff neck | 100 | 55.9 | 52.0 |  |  |  | 79 |  |
 Rash | 0 | 64.7 | 28.0 |  | 71.4 | 28.6 | 16 | 65.7 |
 Fever | 66.7 |  | 80.0 | 95.4 |  |  |  |  |
 Meningeal irritation syndromea | 66.7 |  |  |  |  |  |  |  |
 Seizure | 66.7 | 8.8 | 4.0–12.0 | 7.7 |  |  |  | 11.4 |
 Headache |  | 55.9 | 48.0 |  |  |  | 66.0 | 31.4 |
 Vomiting |  |  | 56.0 |  |  |  |  | 40.0 |
 Altered consciousness |  |  | 48.0 | 27.7 |  |  |  |  |
 Diarrhoea |  |  |  | 9.2 |  |  |  | 11.4 |
 Purpura |  |  |  | 92.3 |  |  |  |  |
 Photophobia |  |  |  |  |  |  | 37 |  |
 Neck pain |  |  |  |  |  |  |  | 17.1 |
 Abdominal pain |  |  |  |  |  |  |  | 5.7 |
 Lethargy |  |  |  |  |  |  |  | 48.6 |
 Irritability |  |  |  |  |  |  |  | 8.6 |
b) Complications at admission and acute complications | |||
---|---|---|---|
Region | EM | NA | |
Reference | Iran [91] | Turkey [97] | Morocco [104] |
Population type | GP | GP | GP |
Number of patients in study | 68 | 65 | 35 |
Date range, year | 1992–2002 | 2000–2005 | 2011–2013 |
Age range, year | Children (0–13) | Children (0.5–10) | Children (0–13) |
Complications at admission and acute complications | |||
 Proportion of patients experiencing complications at admission and acute complications (%) | 2.9–38.2 | 3.1–38.5 | 11.4–54.3 |
 Septic shock | 38.2 | 38.5 |  |
 Conjunctivitis | 2.9 |  |  |
 Pericarditis | 2.9 |  |  |
 Myocarditis |  | 4.6 |  |
 Purpura fulminans |  | 4.6 |  |
 Acute renal failure |  | 3.1 |  |
 ARDS |  | 3.1 |  |
 Arthralgia |  |  | 11.4 |
 Hemodynamic disorder/sepsis |  |  | 54.3 |
c) Post-discharge complications/sequelae | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Region | EM | NA | ||||||||
Reference | Kuwait [93] | Kuwait [94] | Qatar [69] | Qatar [52] | Saudi Arabia [124] | Saudi Arabia [71] | Turkey [98] | Turkey [99] | Egypt [78] | Tunisia [89] |
Population type | GP | GP | GP | GP | GP | P | GP | GP | GP | GP |
Number of patients in study | 30 | 10 | 25 | 2 | 37 | 105 | 2 | 15 | 203 | 79 |
Date range, year | 2001–2003 | 2010–2014 | 1992–2008 | 1998–2000 | 1999–2001 | February–April 2000 | 1994–2004 | 2012–2016 | 1998–2004 | 1997–2006 |
Age range, year | Children (0–12) | Children (0–12) | Children, adults (0–68) | Children, adults (0–100) | Children (0–5) | Adults (18–80) | Children (2–4) | Children (0–18) | Children, adults (0–75) | Children (0–13) |
Post-discharge complications and sequelae | ||||||||||
 Proportion of patients experiencing post-discharge complications/sequelae (%) | 3.4 | 0 | 4.0–24.0 | 0 | 2.7 | 1 | 50 | 33.3 | 5 | 1.3–7.6 |
 Hearing impairment | 3.4 |  |  |  |  |  |  |  |  | 3.8 |
 Motor palsy | 3.4 |  |  |  |  |  |  |  |  |  |
 Aphasia |  |  | 8.0 |  |  |  |  |  |  |  |
 Limb weakness |  |  | 8.0 |  |  |  |  |  |  |  |
 Focal findings |  |  | 16.0 |  |  |  |  |  |  |  |
 Cranial nerve palsy |  |  | 4.0 |  |  |  |  | 33.3 |  |  |
 Amputation |  |  |  |  |  |  | 50.0 |  |  | 1.3 |
 Neurological complication |  |  |  |  |  |  |  |  | 5.0 |  |
Skin necrosis | Â | Â | Â | Â | Â | Â | Â | Â | Â | 7.6 |
Non-specific sequelae | Â | 0.0 | 24.0 | 0.0 | 2.7 | 1.0 | Â | Â | Â | Â |